Laboratorios Farmaceuticos ROVI (ROVI) — Defensive Interval Ratio

Latest as of September 2025: 377 days

Laboratorios Farmaceuticos ROVI (ROVI) has a Defensive Interval Ratio of 377 days as of September 2025. Defensive assets of €191.39 Million (cash €-, short-term investments €-, receivables €191.39 Million) cover 377 days of daily cash needs of €508.00K/day. Check tangible equity quality of Laboratorios Farmaceuticos ROVI to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

377 days
Days of operational coverage

Defensive Assets

€191.39 Million
Cash + ST Investments + Receivables

Daily Cash Need

€508.00K
Current Liabilities ÷ 365

Current Liabilities

€185.42 Million
EUR

Laboratorios Farmaceuticos ROVI Defensive Interval Ratio (2003–2024)

This chart shows how Laboratorios Farmaceuticos ROVI's Defensive Interval Ratio has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the ratio stands at 377 days, meaning defensive assets of €191.39 Million can fund 377 days of operations without new revenue. Also explore Laboratorios Farmaceuticos ROVI equity growth rate to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Laboratorios Farmaceuticos ROVI (2003–2024)

The table below presents the year-by-year Defensive Interval Ratio for Laboratorios Farmaceuticos ROVI from 2003 to 2024, covering 22 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ROVI market cap.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 302 days €129.73 Million €429.18K/day €- €227.00K ▲ +41 days
2023 262 days €143.25 Million €547.52K/day €- €-65.00K ▼ -22 days
2022 284 days €228.52 Million €805.17K/day €44.42 Million €-65.00K ▼ -23 days
2021 307 days €160.00 Million €521.61K/day €- €-65.00K ▲ +57 days
2020 250 days €84.14 Million €336.68K/day €- €-65.00K ▼ -63 days
2019 313 days €91.58 Million €292.35K/day €- €-65.00K ▲ +63 days
2018 251 days €60.12 Million €239.76K/day €- €-65.00K ▲ +46 days
2017 205 days €41.05 Million €200.61K/day €- €-65.00K ▼ -12 days
2016 217 days €45.36 Million €209.43K/day €- €32.00K ▼ -68 days
2015 285 days €46.21 Million €162.26K/day €- €61.00K ▼ -30 days
2014 315 days €53.59 Million €170.18K/day €- €1.22 Million ▼ -56 days
2013 371 days €59.34 Million €159.84K/day €- €1.22 Million ▼ -22 days
2012 393 days €59.35 Million €151.05K/day €- €1.12 Million ▼ -111 days
2011 504 days €78.38 Million €155.50K/day €- €6.00 Million ▼ -115 days
2010 619 days €87.55 Million €141.44K/day €- €26.08 Million ▲ +589 days
2009 29 days €5.15 Million €174.66K/day €- €2.00K ▼ -377 days
2008 406 days €52.39 Million €128.93K/day €- €72.00K ▼ -69 days
2007 475 days €44.97 Million €94.58K/day €- €2.78 Million ▲ +133 days
2006 343 days €34.63 Million €101.09K/day €- €275.00K ▲ +333 days
2005 10 days €89.32 Billion €9.18 Billion/day €- €3.11 Million ▼ -3 days
2004 13 days €130.67 Million €9.95 Million/day €- €12.72 Million ▼ -301 days
2003 314 days €20.74 Million €66.10K/day €- €- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)